Clinical Trial Highlights
Clinical Trial Highlights published on
April 22, 2014
Dr. Volker Diehl discusses two important trials; a US trial for frontline therapy, ECHELON and a GHSG lead trial with escalated BEACOPP.
Clinical Trial Highlights published on
March 24, 2014
Dr. Steidl discusses the significance of tumor-associated macrophages in classical Hodgkin lymphoma.
Clinical Trial Highlights published on
February 18, 2014
Dr. Engert discusses the HD15 trial that explores the quality assurance protocol for reduction of toxicity and the prognostic relevance of FDG-PET in patients with advanced stage Hodgkin lymphoma.
Results 1 - 3 of 3